Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Salim S. Abdool Karim, Ph.D., M.Med., M.B.,Ch.B.

Title
Institution
Department
Address

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U2GPS001350 (ABDOOL KARIM, SALIM S) Sep 30, 2008 - Sep 29, 2014
    CDC/NCHHSTP
    CAPRISA AIDS TREATMENT PROGRAMME
    Role: Principal Investigator
  2. UM1AI069469 (ABDOOL KARIM, QUARRAISHA) Mar 1, 2007 - Nov 30, 2020
    NIH/NIAID
    CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment
    Role: Principal Investigator
  3. U01AI069469 (ABDOOL KARIM, SALIM S) Mar 1, 2007 - Jan 31, 2014
    NIH/NIAID
    University of KwaZulu-Natal - CAPRISA HIV/AIDS Clinical Trials Unit
    Role: Principal Investigator
  4. R21TW006111 (ABDOOL KARIM, SALIM S) Sep 22, 2002 - Sep 21, 2003
    NIH/FIC
    Natal-Columbia Clinical AIDS/TB Training Program
    Role: Principal Investigator
  5. U19AI051794 (ABDOOL KARIM, SALIM S) Jul 1, 2002 - Jun 30, 2008
    NIH/NIAID
    COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Abdool Karim Q, Abdool Karim SS. COVID-19 affects HIV and tuberculosis care. Science. 2020 07 24; 369(6502):366-368. PMID: 32703860.
    Citations:    
  2. Mahomed S, Garrett N, Baxter C, Abdool Karim Q, Abdool Karim SS. Clinical trials of broadly neutralizing monoclonal antibodies for HIV Prevention: A Review. J Infect Dis. 2020 Jun 30. PMID: 32604408.
    Citations:    
  3. Brault MA, Spiegelman D, Abdool Karim SS, Vermund SH. Correction to: Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials. Curr HIV/AIDS Rep. 2020 Jun 30. PMID: 32601917.
    Citations:    
  4. Brault MA, Spiegelman D, Abdool Karim SS, Vermund SH. Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials. Curr HIV/AIDS Rep. 2020 Jun; 17(3):249-258. PMID: 32297219.
    Citations:    
  5. Abdool Karim SS. The South African Response to the Pandemic. N Engl J Med. 2020 06 11; 382(24):e95. PMID: 32469479.
    Citations:    
  6. Drain PK, Dorward J, Violette LR, Quame-Amaglo J, Thomas KK, Samsunder N, Ngobese H, Mlisana K, Moodley P, Donnell D, Barnabas RV, Naidoo K, Abdool Karim SS, Celum C, Garrett N. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial. Lancet HIV. 2020 Apr; 7(4):e229-e237. PMID: 32105625.
    Citations:    
  7. Molatlhegi RP, Liebenberg LJ, Leslie A, Noel-Romas L, Mabhula A, Mchunu N, Perner M, Birse K, Ngcapu S, Adamson JH, Govender K, Garrett NJ, Samsunder N, Burgener AD, Abdool Karim SS, Abdool Karim Q, Passmore JS, McKinnon LR. Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women. Mucosal Immunol. 2020 05; 13(3):449-459. PMID: 31896762.
    Citations:    
  8. Richardson SI, Lambson BE, Crowley AR, Bashirova A, Scheepers C, Garrett N, Abdool Karim S, Mkhize NN, Carrington M, Ackerman ME, Moore PL, Morris L. IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody. PLoS Pathog. 2019 12; 15(12):e1008064. PMID: 31841557.
    Citations:    
  9. Mielke D, Bandawe G, Pollara J, Abrahams MR, Nyanhete T, Moore PL, Thebus R, Yates NL, Kappes JC, Ochsenbauer C, Garrett N, Abdool Karim S, Tomaras GD, Montefiori D, Morris L, Ferrari G, Williamson C. Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway. Front Immunol. 2019; 10:2875. PMID: 31921139.
    Citations:    
  10. Liebenberg LJP, McKinnon LR, Yende-Zuma N, Garrett N, Baxter C, Kharsany ABM, Archary D, Rositch A, Samsunder N, Mansoor LE, Passmore JS, Abdool Karim SS, Abdool Karim Q. HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition. Nat Commun. 2019 11 19; 10(1):5227. PMID: 31745084.
    Citations:    
  11. Kharsany ABM, Cawood C, Lewis L, Yende-Zuma N, Khanyile D, Puren A, Madurai S, Baxter C, George G, Govender K, Beckett S, Samsunder N, Toledo C, Ayalew KA, Diallo K, Glenshaw M, Herman-Roloff A, Wilkinson E, de Oliveira T, Abdool Karim SS, Abdool Karim Q. Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa. JAMA Netw Open. 2019 11 01; 2(11):e1914378. PMID: 31675082.
    Citations:    
  12. Mwatelah R, McKinnon LR, Baxter C, Abdool Karim Q, Abdool Karim SS. Mechanisms of sexually transmitted infection-induced inflammation in women: implications for HIV risk. J Int AIDS Soc. 2019 08; 22 Suppl 6:e25346. PMID: 31468677.
    Citations:    
  13. Cromarty R, Sigal A, Liebenberg LJP, McKinnon LR, Abdool Karim SS, Passmore JS, Archary D. Diminished HIV Infection of Target CD4+ T Cells in a Toll-Like Receptor 4 Stimulated in vitro Model. Front Immunol. 2019; 10:1705. PMID: 31396221.
    Citations:    
  14. Abdool Karim SS. HIV-1 Epidemic Control - Insights from Test-and-Treat Trials. N Engl J Med. 2019 07 18; 381(3):286-288. PMID: 31314975.
    Citations:    
  15. Mahomed S, Garrett N, Capparelli E, Baxter C, Zuma NY, Gengiah T, Archary D, Moore P, Samsunder N, Barouch DH, Mascola J, Ledgerwood J, Morris L, Abdool Karim S. Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial. BMJ Open. 2019 07 03; 9(7):e030283. PMID: 31272988.
    Citations:    
  16. Baxter C, Ngcapu S, Blackard JT, Powell EA, Penton PK, Abdool Karim SS. Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis. Viruses. 2019 06 19; 11(6). PMID: 31248149.
    Citations:    
  17. Naidoo K, Gengiah S, Yende-Zuma N, Padayatchi N, Barker P, Nunn A, Subrayen P, Abdool Karim SS. Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol. Implement Sci. 2019 06 13; 14(1):59. PMID: 31196142.
    Citations:    
  18. van den Berg FT, Makoah NA, Ali SA, Scott TA, Mapengo RE, Mutsvunguma LZ, Mkhize NN, Lambson BE, Kgagudi PD, Crowther C, Abdool Karim SS, Balazs AB, Weinberg MS, Ely A, Arbuthnot PB, Morris L. AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region. Mol Ther Methods Clin Dev. 2019 Sep 13; 14:100-112. PMID: 31334303.
    Citations:    
  19. Mabvakure BM, Lambson BE, Ramdayal K, Masson L, Kitchin D, Allam M, Abdool Karim S, Williamson C, Passmore JA, Martin DP, Scheepers C, Moore PL, Harkins GW, Morris L. Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract. J Virol. 2019 05 15; 93(10). PMID: 30842323.
    Citations:    
  20. Abdool Karim SS, Baxter C, Passmore JS, McKinnon LR, Williams BL. The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women. J Int AIDS Soc. 2019 05; 22(5):e25300. PMID: 31144462.
    Citations:    
  21. Chimukangara B, Lessells RJ, Rhee SY, Giandhari J, Kharsany ABM, Naidoo K, Lewis L, Cawood C, Khanyile D, Ayalew KA, Diallo K, Samuel R, Hunt G, Vandormael A, Stray-Pedersen B, Gordon M, Makadzange T, Kiepiela P, Ramjee G, Ledwaba J, Kalimashe M, Morris L, Parikh UM, Mellors JW, Shafer RW, Katzenstein D, Moodley P, Gupta RK, Pillay D, Abdool Karim SS, de Oliveira T. Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis. EClinicalMedicine. 2019 Mar; 9:26-34. PMID: 31143879.
    Citations:    
  22. Mabvakure BM, Scheepers C, Garrett N, Abdool Karim S, Williamson C, Morris L, Moore PL. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies. J Virol. 2019 03 15; 93(6). PMID: 30567996.
    Citations:    
  23. Johnson EL, Doria-Rose NA, Gorman J, Bhiman JN, Schramm CA, Vu AQ, Law WH, Zhang B, Bekker V, Abdool Karim SS, Ippolito GC, Morris L, Moore PL, Kwong PD, Mascola JR, Georgiou G. Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation. Nat Commun. 2018 10 08; 9(1):4136. PMID: 30297708.
    Citations:    
  24. Sheward DJ, Marais J, Bekker V, Murrell B, Eren K, Bhiman JN, Nonyane M, Garrett N, Woodman ZL, Abdool Karim Q, Abdool Karim SS, Morris L, Moore PL, Williamson C. HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth. Cell Host Microbe. 2018 10 10; 24(4):593-599.e3. PMID: 30269971.
    Citations:    
  25. Joag V, Sivro A, Yende-Zuma N, Imam H, Samsunder N, Abdool Karim Q, Abdool Karim S, McKinnon L, Kaul R. Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women. PLoS One. 2018; 13(7):e0200359. PMID: 29985942.
    Citations:    
  26. Barré-Sinoussi F, Abdool Karim SS, Albert J, Bekker LG, Beyrer C, Cahn P, Calmy A, Grinsztejn B, Grulich A, Kamarulzaman A, Kumarasamy N, Loutfy MR, El Filali KM, Mboup S, Montaner JS, Munderi P, Pokrovsky V, Vandamme AM, Young B, Godfrey-Faussett P. Expert consensus statement on the science of HIV in the context of criminal law. J Int AIDS Soc. 2018 07; 21(7):e25161. PMID: 30044059.
    Citations:    
  27. Abdool Karim Q, Abdool Karim SS. HIV-No time for complacency. Science. 2018 06 15; 360(6394):1153. PMID: 29903942.
    Citations:    
  28. Tanko RF, Soares AP, Masson L, Garrett NJ, Samsunder N, Abdool Karim Q, Abdool Karim SS, Riou C, Burgers WA. Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression. Clin Immunol. 2018 10; 195:127-138. PMID: 29883708.
    Citations:    
  29. Dorward J, Lessells R, Drain PK, Naidoo K, de Oliveira T, Pillay Y, Abdool Karim SS, Garrett N. Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research. Lancet HIV. 2018 07; 5(7):e400-e404. PMID: 29884404.
    Citations:    
  30. Garrett NJ, Osman F, Maharaj B, Naicker N, Gibbs A, Norman E, Samsunder N, Ngobese H, Mitchev N, Singh R, Abdool Karim SS, Kharsany ABM, Mlisana K, Rompalo A, Mindel A. Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries. PLoS One. 2018; 13(4):e0196209. PMID: 29689080.
    Citations:    
  31. Anthony C, York T, Bekker V, Matten D, Selhorst P, Ferreria RC, Garrett NJ, Abdool Karim SS, Morris L, Wood NT, Moore PL, Williamson C. Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope". J Virol. 2018 05 01; 92(9). PMID: 29654221.
    Citations:    
  32. Richardson SI, Chung AW, Natarajan H, Mabvakure B, Mkhize NN, Garrett N, Abdool Karim S, Moore PL, Ackerman ME, Alter G, Morris L. HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies. PLoS Pathog. 2018 04; 14(4):e1006987. PMID: 29630668.
    Citations: 3     Fields:    Translation:HumansCells
  33. Moosa Y, Tanko RF, Ramsuran V, Singh R, Madzivhandila M, Yende-Zuma N, Abrahams MR, Selhorst P, Gounder K, Moore PL, Williamson C, Abdool Karim SS, Garrett NJ, Burgers WA. Case report: mechanisms of HIV elite control in two African women. BMC Infect Dis. 2018 01 25; 18(1):54. PMID: 29370775.
    Citations:    
  34. Sivro A, Schuetz A, Sheward D, Joag V, Yegorov S, Liebenberg LJ, Yende-Zuma N, Stalker A, Mwatelah RS, Selhorst P, Garrett N, Samsunder N, Balgobin A, Nawaz F, Cicala C, Arthos J, Fauci AS, Anzala AO, Kimani J, Bagaya BS, Kiwanuka N, Williamson C, Kaul R, Passmore JS, Phanuphak N, Ananworanich J, Ansari A, Abdool Karim Q, Abdool Karim SS, McKinnon LR. Integrin a4ß7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes. Sci Transl Med. 2018 01 24; 10(425). PMID: 29367348.
    Citations:    
  35. Abdool Karim SS, Passmore JS, Baxter C. The microbiome and HIV prevention strategies in women. Curr Opin HIV AIDS. 2018 Jan; 13(1):81-87. PMID: 29059077.
    Citations:    
  36. Naidoo K, Gengiah S, Yende-Zuma N, Padayatchi N, Barker P, Nunn A, Subrayen P, Abdool Karim SS. Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol. Implement Sci. 2017 Nov 13; 12(1):129. PMID: 29132380.
    Citations:    
  37. Scheepers C, Chowdhury S, Wright WS, Campbell CT, Garrett NJ, Abdool Karim Q, Abdool Karim SS, Moore PL, Gildersleeve JC, Morris L. Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses. AIDS. 2017 10 23; 31(16):2199-2209. PMID: 28926408.
    Citations:    
  38. Dorward J, Garrett N, Quame-Amaglo J, Samsunder N, Ngobese H, Ngomane N, Moodley P, Mlisana K, Schaafsma T, Donnell D, Barnabas R, Naidoo K, Abdool Karim S, Celum C, Drain PK. Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study. BMJ Open. 2017 Sep 27; 7(9):e017507. PMID: 28963304.
    Citations:    
  39. Julg B, Tartaglia LJ, Keele BF, Wagh K, Pegu A, Sok D, Abbink P, Schmidt SD, Wang K, Chen X, Joyce MG, Georgiev IS, Choe M, Kwong PD, Doria-Rose NA, Le K, Louder MK, Bailer RT, Moore PL, Korber B, Seaman MS, Abdool Karim SS, Morris L, Koup RA, Mascola JR, Burton DR, Barouch DH. Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge. Sci Transl Med. 2017 09 06; 9(406). PMID: 28878010.
    Citations: 9     Fields:    Translation:AnimalsCells
  40. Ngandu NK, Carlson JM, Chopera DR, Ndabambi N, Abdool Karim Q, Abdool Karim S, Williamson C. Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide. J Acquir Immune Defic Syndr. 2017 09 01; 76(1):43-47. PMID: 28797020.
    Citations:    
  41. Sivro A, McKinnon LR, Yende-Zuma N, Gengiah S, Samsunder N, Abdool Karim SS, Naidoo K. Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa. Clin Infect Dis. 2017 Sep 01; 65(5):819-826. PMID: 29017282.
    Citations:    
  42. Klatt NR, Cheu R, Birse K, Zevin AS, Perner M, Noël-Romas L, Grobler A, Westmacott G, Xie IY, Butler J, Mansoor L, McKinnon LR, Passmore JS, Abdool Karim Q, Abdool Karim SS, Burgener AD. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science. 2017 06 02; 356(6341):938-945. PMID: 28572388.
    Citations:    
  43. Selhorst P, Combrinck C, Ndabambi N, Ismail SD, Abrahams MR, Lacerda M, Samsunder N, Garrett N, Abdool Karim Q, Abdool Karim SS, Williamson C. Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression. J Virol. 2017 04 15; 91(8). PMID: 28148791.
    Citations:    
  44. Mabvakure B, Scheepers C, Nonyane M, Lambson B, Madzorera S, Kitchin D, Bhiman J, Wibmer K, Abdool Karim S, Williamson C, Morris L, Moore PL. A38 Diversity analyses of HIV-1 envelope glycoproteins in HIV-infected individuals with and without broadly neutralizing antibodies. Virus Evol. 2017 Mar; 3(Suppl 1). PMID: 28845277.
    Citations:    
  45. Liebenberg LJ, Masson L, Arnold KB, Mckinnon LR, Werner L, Proctor E, Archary D, Mansoor LE, Lauffenburger DA, Abdool Karim Q, Abdool Karim SS, Passmore JS. Genital-Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women. J Acquir Immune Defic Syndr. 2017 Mar 01; 74(3):318-325. PMID: 28187085.
    Citations: 3     Fields:    
  46. Chopera DR, Ntale R, Ndabambi N, Garrett N, Gray CM, Matten D, Abdool Karim Q, Abdool Karim S, Williamson C. Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women. AIDS. 2017 01 14; 31(2):191-197. PMID: 27755110.
    Citations:    
  47. Wibmer CK, Gorman J, Ozorowski G, Bhiman JN, Sheward DJ, Elliott DH, Rouelle J, Smira A, Joyce MG, Ndabambi N, Druz A, Asokan M, Burton DR, Connors M, Abdool Karim SS, Mascola JR, Robinson JE, Ward AB, Williamson C, Kwong PD, Morris L, Moore PL. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. PLoS Pathog. 2017 01; 13(1):e1006074. PMID: 28076415.
    Citations:    
  48. Doria-Rose NA, Altae-Tran HR, Roark RS, Schmidt SD, Sutton MS, Louder MK, Chuang GY, Bailer RT, Cortez V, Kong R, McKee K, O'Dell S, Wang F, Abdool Karim SS, Binley JM, Connors M, Haynes BF, Martin MA, Montefiori DC, Morris L, Overbaugh J, Kwong PD, Mascola JR, Georgiev IS. Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting. PLoS Pathog. 2017 01; 13(1):e1006148. PMID: 28052137.
    Citations:    
  49. Tanko RF, Soares AP, Müller TL, Garrett NJ, Samsunder N, Abdool Karim Q, Abdool Karim SS, Riou C, Burgers WA. Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women. J Immunol. 2017 02 01; 198(3):1220-1228. PMID: 28039305.
    Citations:    
  50. Sobieszczyk ME, Werner L, Mlisana K, Naicker N, Feinstein A, Gray CM, Masson L, Passmore JS, Williamson C, Abdool Karim Q, Abdool Karim SS, Garrett NJ. Metabolic Syndrome After HIV Acquisition in South African Women. J Acquir Immune Defic Syndr. 2016 Dec 01; 73(4):438-445. PMID: 27391387.
    Citations:    
  51. Wibmer CK, Gorman J, Anthony CS, Mkhize NN, Druz A, York T, Schmidt SD, Labuschagne P, Louder MK, Bailer RT, Abdool Karim SS, Mascola JR, Williamson C, Moore PL, Kwong PD, Morris L. Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site. J Virol. 2016 Nov 15; 90(22):10220-10235. PMID: 27581986.
    Citations:    
  52. Selhorst P, Masson L, Ismail SD, Samsunder N, Garrett N, Mansoor LE, Abdool Karim Q, Abdool Karim SS, Passmore JS, Williamson C. Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants. Clin Infect Dis. 2017 Jan 01; 64(1):79-82. PMID: 27694480.
    Citations:    
  53. Madlala P, Singh R, An P, Werner L, Mlisana K, Abdool Karim SS, Winkler CA, Ndung'u T. Association of Polymorphisms in the Regulatory Region of the Cyclophilin a Gene (PPIA) with Gene Expression and HIV/AIDS Disease Progression. J Acquir Immune Defic Syndr. 2016 08 15; 72(5):465-73. PMID: 27088296.
    Citations:    Fields:    Translation:HumansCells
  54. Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, Diphoko TE, Hraber P, Tumba N, Moore PL, Gray GE, Kublin J, McElrath MJ, Vermeulen M, Middelkoop K, Bekker LG, Hoelscher M, Maboko L, Makhema J, Robb ML, Abdool Karim S, Abdool Karim Q, Kim JH, Hahn BH, Gao F, Swanstrom R, Morris L, Montefiori DC, Williamson C. Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization. PLoS Pathog. 2016 07; 12(7):e1005742. PMID: 27434311.
    Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
  55. Baxter C, Abdool Karim S. Combination HIV prevention options for young women in Africa. Afr J AIDS Res. 2016 Jul; 15(2):109-21. PMID: 27399041.
    Citations:    
  56. Garrett NJ, Drain PK, Werner L, Samsunder N, Abdool Karim SS. Diagnostic Accuracy of the Point-of-Care Xpert HIV-1 Viral Load Assay in a South African HIV Clinic. J Acquir Immune Defic Syndr. 2016 06 01; 72(2):e45-8. PMID: 26959192.
    Citations: 6     Fields:    Translation:HumansCells
  57. Shey MS, Maharaj N, Archary D, Ngcapu S, Garrett N, Abdool Karim S, Passmore JA. Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists. PLoS One. 2016; 11(5):e0155668. PMID: 27171482.
    Citations:    
  58. Archary D, Seaton KE, Passmore JS, Werner L, Deal A, Dunphy LJ, Arnold KB, Yates NL, Lauffenburger DA, Bergin P, Liebenberg LJ, Samsunder N, Mureithi MW, Altfeld M, Garrett N, Abdool Karim Q, Abdool Karim SS, Morris L, Tomaras GD. Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel. Mucosal Immunol. 2016 05; 9(3):834. PMID: 27116933.
    Citations:    Fields:    
  59. Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM. Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31]. Contraception. 2016 Jul; 94(1):95. PMID: 27085419.
    Citations:    
  60. Gray GE, Laher F, Doherty T, Abdool Karim S, Hammer S, Mascola J, Beyrer C, Corey L. Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? PLoS Biol. 2016 Mar; 14(3):e1002372. PMID: 26933962.
    Citations:    
  61. Kløverpris HN, Kazer SW, Mjösberg J, Mabuka JM, Wellmann A, Ndhlovu Z, Yadon MC, Nhamoyebonde S, Muenchhoff M, Simoni Y, Andersson F, Kuhn W, Garrett N, Burgers WA, Kamya P, Pretorius K, Dong K, Moodley A, Newell EW, Kasprowicz V, Abdool Karim SS, Goulder P, Shalek AK, Walker BD, Ndung'u T, Leslie A. Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. Immunity. 2016 Feb 16; 44(2):391-405. PMID: 26850658.
    Citations: 26     Fields:    Translation:HumansCells
  62. Naranbhai V, de Assis Rosa D, Werner L, Moodley R, Hong H, Kharsany A, Mlisana K, Sibeko S, Garrett N, Chopera D, Carr WH, Abdool Karim Q, Hill AV, Abdool Karim SS, Altfeld M, Gray CM, Ndung'u T. Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women. BMC Infect Dis. 2016 Jan 25; 16:27. PMID: 26809736.
    Citations: 1     Fields:    Translation:HumansCells
  63. Abdool Karim SS, Abdool Karim Q, Gengiah TN. Tenofovir Gel to Prevent HSV-2 Infection. N Engl J Med. 2015 11 12; 373(20):1980-1. PMID: 26559584.
    Citations:    
  64. Kharsany AB, Frohlich JA, Yende-Zuma N, Mahlase G, Samsunder N, Dellar RC, Zuma-Mkhonza M, Abdool Karim SS, Abdool Karim Q. Trends in HIV Prevalence in Pregnant Women in Rural South Africa. J Acquir Immune Defic Syndr. 2015 Nov 01; 70(3):289-95. PMID: 26186507.
    Citations:    
  65. Masson L, Arnold KB, Little F, Mlisana K, Lewis DA, Mkhize N, Gamieldien H, Ngcapu S, Johnson L, Lauffenburger DA, Abdool Karim Q, Abdool Karim SS, Passmore JA. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection. Sex Transm Infect. 2016 May; 92(3):186-93. PMID: 26511781.
    Citations:    
  66. Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. Contraception. 2016 Jan; 93(1):25-31. PMID: 26519646.
    Citations:    
  67. Masson L, Salkinder AL, Olivier AJ, McKinnon LR, Gamieldien H, Mlisana K, Scriba TJ, Lewis DA, Little F, Jaspan HB, Ronacher K, Denny L, Abdool Karim SS, Passmore JA. Relationship between female genital tract infections, mucosal interleukin-17 production and local T helper type 17 cells. Immunology. 2015 Dec; 146(4):557-67. PMID: 26302175.
    Citations:    
  68. Gengiah TN, Botha JH, Yende-Zuma N, Naidoo K, Abdool Karim SS. Efavirenz dosing: influence of drug metabolizing enzyme polymorphisms and concurrent tuberculosis treatment. Antivir Ther. 2015; 20(3):297-306. PMID: 25318122.
    Citations:    
  69. Bhiman JN, Anthony C, Doria-Rose NA, Karimanzira O, Schramm CA, Khoza T, Kitchin D, Botha G, Gorman J, Garrett NJ, Abdool Karim SS, Shapiro L, Williamson C, Kwong PD, Mascola JR, Morris L, Moore PL. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies. Nat Med. 2015 Nov; 21(11):1332-6. PMID: 26457756.
    Citations:    
  70. Naidoo K, Grobler AC, Deghaye N, Reddy T, Gengiah S, Gray A, Abdool Karim S. Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa. J Acquir Immune Defic Syndr. 2015 Aug 15; 69(5):576-84. PMID: 26167618.
    Citations:    
  71. Gornalusse GG, Mummidi S, Gaitan AA, Jimenez F, Ramsuran V, Picton A, Rogers K, Manoharan MS, Avadhanam N, Murthy KK, Martinez H, Molano Murillo A, Chykarenko ZA, Hutt R, Daskalakis D, Shostakovich-Koretskaya L, Abdool Karim S, Martin JN, Deeks SG, Hecht F, Sinclair E, Clark RA, Okulicz J, Valentine FT, Martinson N, Tiemessen CT, Ndung'u T, Hunt PW, He W, Ahuja SK. Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor. Proc Natl Acad Sci U S A. 2015 Aug 25; 112(34):E4762-71. PMID: 26307764.
    Citations:    
  72. Abdool Karim SS, Abdool Karim Q, Kharsany AB, Baxter C, Grobler AC, Werner L, Kashuba A, Mansoor LE, Samsunder N, Mindel A, Gengiah TN. Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection. N Engl J Med. 2015 Aug 06; 373(6):530-9. PMID: 26244306.
    Citations:    
  73. Abdool Karim SS. Overcoming Impediments to Global Implementation of Early Antiretroviral Therapy. N Engl J Med. 2015 Aug 27; 373(9):875-6. PMID: 26193047.
    Citations:    
  74. Pellett Madan R, Masson L, Tugetman J, Werner L, Grobler A, Mlisana K, Lo Y, Che D, Arnold KB, Abdool Karim SS, Passmore JA, Herold BC. Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition. AIDS Res Hum Retroviruses. 2015 Nov; 31(11):1153-9. PMID: 26061218.
    Citations:    
  75. Archary D, Liebenberg LJ, Werner L, Tulsi S, Majola N, Naicker N, Dlamini S, Hope TJ, Samsunder N, Abdool Karim SS, Morris L, Passmore JA, Garrett NJ. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage. PLoS One. 2015; 10(7):e0131906. PMID: 26147923.
    Citations:    
  76. Naicker N, Kharsany AB, Werner L, van Loggerenberg F, Mlisana K, Garrett N, Abdool Karim SS. Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting. AIDS Behav. 2015 Jul; 19(7):1305-16. PMID: 25662962.
    Citations:    
  77. Kashuba AD, Gengiah TN, Werner L, Yang KH, White NR, Karim QA, Abdool Karim SS. Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness. J Acquir Immune Defic Syndr. 2015 Jul 01; 69(3):264-9. PMID: 26181703.
    Citations:    
  78. Arnold KB, Burgener A, Birse K, Romas L, Dunphy LJ, Shahabi K, Abou M, Westmacott GR, McCorrister S, Kwatampora J, Nyanga B, Kimani J, Masson L, Liebenberg LJ, Abdool Karim SS, Passmore JA, Lauffenburger DA, Kaul R, McKinnon LR. Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells. Mucosal Immunol. 2016 Jan; 9(1):194-205. PMID: 26104913.
    Citations:    
  79. Piot P, Abdool Karim SS, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E, Watts C, Kilonzo N, McManus J, Sidibé M. Defeating AIDS--advancing global health. Lancet. 2015 Jul 11; 386(9989):171-218. PMID: 26117719.
    Citations: 60     Fields:    Translation:HumansPHPublic Health
  80. Abdool Karim SS, Abdool Karim Q, Baxter C. Antibodies for HIV prevention in young women. Curr Opin HIV AIDS. 2015 May; 10(3):183-9. PMID: 25700207.
    Citations:    
  81. Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, Lauffenburger DA, Ronacher K, Walzl G, Garrett NJ, Williams BL, Couto-Rodriguez M, Hornig M, Lipkin WI, Grobler A, Abdool Karim Q, Abdool Karim SS. Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis. 2015 Jul 15; 61(2):260-9. PMID: 25900168.
    Citations: 51     Fields:    Translation:Humans
  82. Scheepers C, Shrestha RK, Lambson BE, Jackson KJ, Wright IA, Naicker D, Goosen M, Berrie L, Ismail A, Garrett N, Abdool Karim Q, Abdool Karim SS, Moore PL, Travers SA, Morris L. Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire. J Immunol. 2015 May 01; 194(9):4371-8. PMID: 25825450.
    Citations:    
  83. Sheward DJ, Ntale R, Garrett NJ, Woodman ZL, Abdool Karim SS, Williamson C. HIV-1 Superinfection Resembles Primary Infection. J Infect Dis. 2015 Sep 15; 212(6):904-8. PMID: 25754982.
    Citations:    
  84. Laeyendecker O, Redd AD, Nason M, Longosz AF, Karim QA, Naranbhai V, Garrett N, Eshleman SH, Abdool Karim SS, Quinn TC. Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. J Infect Dis. 2015 Sep 01; 212(5):754-9. PMID: 25712973.
    Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
  85. Abdool Karim Q, Dellar RC, Bearnot B, Werner L, Frohlich JA, Kharsany AB, Abdool Karim SS. HIV-positive status disclosure in patients in care in rural South Africa: implications for scaling up treatment and prevention interventions. AIDS Behav. 2015 Feb; 19(2):322-9. PMID: 25677128.
    Citations: 4     Fields:    Translation:Humans
  86. van Loggerenberg F, Grant AD, Naidoo K, Murrman M, Gengiah S, Gengiah TN, Fielding K, Abdool Karim SS. Individualised motivational counselling to enhance adherence to antiretroviral therapy is not superior to didactic counselling in South African patients: findings of the CAPRISA 058 randomised controlled trial. AIDS Behav. 2015 Jan; 19(1):145-56. PMID: 24696226.
    Citations:    
  87. Mansoor LE, Abdool Karim Q, Mngadi KT, Dlamini S, Montague C, Nkomonde N, Mvandaba N, Baxter C, Gengiah TN, Samsunder N, Dawood H, Grobler A, Frohlich JA, Abdool Karim SS. Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial. Trials. 2014 Dec 19; 15:496. PMID: 25527071.
    Citations:    
  88. Bandawe GP, Moore PL, Werner L, Gray ES, Sheward DJ, Madiga M, Nofemela A, Thebus R, Marais JC, Maboko L, Abdool Karim SS, Hoelscher M, Morris L, Williamson C. Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa. J Infect Dis. 2015 May 01; 211(9):1461-6. PMID: 25398460.
    Citations:    
  89. Penrose KJ, Richardson BA, Besson G, Dezzutti CS, Herold BC, Abdool Karim SS, Mellors JW, Parikh UM. Y chromosome and HIV DNA detection in vaginal swabs as biomarkers of semen and HIV exposure in women. Sex Transm Dis. 2014 Nov; 41(11):674-9. PMID: 25299415.
    Citations:    
  90. Abdool Karim SS. Mervyn W. Susser - his contributions to the acquired immune deficiency syndrome response in South Africa. Paediatr Perinat Epidemiol. 2014 Nov; 28(6):473-5. PMID: 25361056.
    Citations:    
  91. Ritchie AJ, Cai F, Smith NM, Chen S, Song H, Brackenridge S, Abdool Karim SS, Korber BT, McMichael AJ, Gao F, Goonetilleke N. Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection. Retrovirology. 2014 Sep 12; 11:69. PMID: 25212771.
    Citations:    
  92. Mann JK, Chopera D, Omarjee S, Kuang XT, Le AQ, Anmole G, Danroth R, Mwimanzi P, Reddy T, Carlson J, Radebe M, Goulder PJR, Walker BD, Abdool Karim S, Novitsky V, Williamson C, Brockman MA, Brumme ZL, Ndung'u T. Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure. Virology. 2014 Nov; 468-470:214-225. PMID: 25193656.
    Citations: 5     Fields:    Translation:HumansCells
  93. Dellar RC, Abdool Karim Q, Mansoor LE, Grobler A, Humphries H, Werner L, Ntombela F, Luthuli L, Abdool Karim SS. The preventive misconception: experiences from CAPRISA 004. AIDS Behav. 2014 Sep; 18(9):1746-52. PMID: 24715227.
    Citations:    
  94. Tomita A, Garrett N, Werner L, Burns JK, Ngcobo N, Zuma N, Mlisana K, van Loggerenberg F, Abdool Karim SS. Impact of antiretroviral therapy on health-related quality of life among South African women in the CAPRISA 002 acute infection study. AIDS Behav. 2014 Sep; 18(9):1801-7. PMID: 24849623.
    Citations:    
  95. Gengiah TN, Botha JH, Soowamber D, Naidoo K, Abdool Karim SS. Low rifampicin concentrations in tuberculosis patients with HIV infection. J Infect Dev Ctries. 2014 Aug 13; 8(8):987-93. PMID: 25116663.
    Citations:    
  96. Masson L, Mlisana K, Little F, Werner L, Mkhize NN, Ronacher K, Gamieldien H, Williamson C, Mckinnon LR, Walzl G, Abdool Karim Q, Abdool Karim SS, Passmore JA. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study. Sex Transm Infect. 2014 Dec; 90(8):580-7. PMID: 25107710.
    Citations:    
  97. Mlisana K, Werner L, Garrett NJ, McKinnon LR, van Loggerenberg F, Passmore JA, Gray CM, Morris L, Williamson C, Abdool Karim SS. Rapid disease progression in HIV-1 subtype C-infected South African women. Clin Infect Dis. 2014 Nov 01; 59(9):1322-31. PMID: 25038116.
    Citations:    
  98. Tomita A, Garrett N, Werner L, Burns JK, Mpanza L, Mlisana K, van Loggerenberg F, Abdool Karim SS. Health-related quality of life dynamics of HIV-positive South African women up to ART initiation: evidence from the CAPRISA 002 acute infection cohort study. AIDS Behav. 2014 Jun; 18(6):1114-23. PMID: 24368630.
    Citations:    
  99. Abdool Karim Q, Kharsany AB, Leask K, Ntombela F, Humphries H, Frohlich JA, Samsunder N, Grobler A, Dellar R, Abdool Karim SS. Prevalence of HIV, HSV-2 and pregnancy among high school students in rural KwaZulu-Natal, South Africa: a bio-behavioural cross-sectional survey. Sex Transm Infect. 2014 Dec; 90(8):620-6. PMID: 24873967.
    Citations:    
  100. Mansoor LE, Abdool Karim Q, Yende-Zuma N, MacQueen KM, Baxter C, Madlala BT, Grobler A, Abdool Karim SS. Adherence in the CAPRISA 004 tenofovir gel microbicide trial. AIDS Behav. 2014 May; 18(5):811-9. PMID: 24643315.
    Citations:    
  101. Mngadi KT, Maarschalk S, Grobler AC, Mansoor LE, Frohlich JA, Madlala B, Ngcobo N, Abdool Karim SS, Abdool Karim Q. Disclosure of microbicide gel use to sexual partners: influence on adherence in the CAPRISA 004 trial. AIDS Behav. 2014 May; 18(5):849-54. PMID: 24633715.
    Citations:    
  102. Gengiah TN, Upfold M, Naidoo A, Mansoor LE, Feldblum PJ, Abdool Karim Q, Abdool Karim SS. Monitoring microbicide gel use with real-time notification of the container's opening events: results of the CAPRISA Wisebag study. AIDS Behav. 2014 May; 18(5):833-40. PMID: 24643314.
    Citations:    
  103. Naidoo K, Karim QA, Bhushan A, Naidoo K, Yende-Zuma N, McHunu PK, Frohlich J, Karim F, Upfold M, Kocheleff P, Abdool Karim SS. High rates of tuberculosis in patients accessing HAART in rural South Africa. J Acquir Immune Defic Syndr. 2014 Apr 01; 65(4):438-46. PMID: 24256629.
    Citations:    
  104. Doria-Rose NA, Schramm CA, Gorman J, Moore PL, Bhiman JN, DeKosky BJ, Ernandes MJ, Georgiev IS, Kim HJ, Pancera M, Staupe RP, Altae-Tran HR, Bailer RT, Crooks ET, Cupo A, Druz A, Garrett NJ, Hoi KH, Kong R, Louder MK, Longo NS, McKee K, Nonyane M, O'Dell S, Roark RS, Rudicell RS, Schmidt SD, Sheward DJ, Soto C, Wibmer CK, Yang Y, Zhang Z, Mullikin JC, Binley JM, Sanders RW, Wilson IA, Moore JP, Ward AB, Georgiou G, Williamson C, Abdool Karim SS, Morris L, Kwong PD, Shapiro L, Mascola JR. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature. 2014 May 01; 509(7498):55-62. PMID: 24590074.
    Citations:    
  105. Padayatchi N, Abdool Karim SS, Naidoo K, Grobler A, Friedland G. Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial. Int J Tuberc Lung Dis. 2014 Feb; 18(2):147-54. PMID: 24429305.
    Citations:    
  106. Balkus JE, Richardson BA, Rabe LK, Taha TE, Mgodi N, Kasaro MP, Ramjee G, Hoffman IF, Abdool Karim SS. Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV-1-negative women. Sex Transm Dis. 2014 Feb; 41(2):123-8. PMID: 24413493.
    Citations:    
  107. Singh R, Patel V, Mureithi MW, Naranbhai V, Ramsuran D, Tulsi S, Hiramen K, Werner L, Mlisana K, Altfeld M, Luban J, Kasprowicz V, Dheda K, Abdool Karim SS, Ndung'u T. TRIM5a and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment. J Virol. 2014 Apr; 88(8):4291-303. PMID: 24478420.
    Citations: 6     Fields:    Translation:HumansCells
  108. Wei X, Hunt G, Abdool Karim SS, Naranbhai V, Sibeko S, Abdool Karim Q, Li JF, Kashuba AD, Werner L, Passmore JA, Morris L, Heneine W, Johnson JA. Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial. J Infect Dis. 2014 Jun 15; 209(12):1916-20. PMID: 24436453.
    Citations: 5     Fields:    Translation:HumansCells
  109. Abdool Karim SS. Retrospective. Nelson R. Mandela (1918-2013). Science. 2014 Jan 10; 343(6167):150. PMID: 24408428.
    Citations:    
  110. Abdool Karim SS, Baxter C. Microbicides for prevention of HIV infection: clinical efficacy trials. Curr Top Microbiol Immunol. 2014; 383:97-115. PMID: 23695725.
    Citations:    
  111. Redd AD, Mullis CE, Wendel SK, Sheward D, Martens C, Bruno D, Werner L, Garrett NJ, Abdool Karim Q, Williamson C, Porcella SF, Quinn TC, Abdool Karim SS. Limited HIV-1 superinfection in seroconverters from the CAPRISA 004 Microbicide Trial. J Clin Microbiol. 2014 Mar; 52(3):844-8. PMID: 24371237.
    Citations:    
  112. Riou C, Burgers WA, Mlisana K, Koup RA, Roederer M, Abdool Karim SS, Williamson C, Gray CM. Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point. J Virol. 2014 Feb; 88(3):1819-24. PMID: 24227857.
    Citations:    
  113. Wibmer CK, Bhiman JN, Gray ES, Tumba N, Abdool Karim SS, Williamson C, Morris L, Moore PL. Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. PLoS Pathog. 2013 Oct; 9(10):e1003738. PMID: 24204277.
    Citations:    
  114. Naranbhai V, Hill AV, Abdool Karim SS, Naidoo K, Abdool Karim Q, Warimwe GM, McShane H, Fletcher H. Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy. J Infect Dis. 2014 Feb 15; 209(4):500-9. PMID: 24041796.
    Citations: 25     Fields:    Translation:HumansCells
  115. Baxter C, Yende-Zuma N, Tshabalala P, Abdool Karim Q, Abdool Karim SS. Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: results from the CAPRISA 004 trial. Antiviral Res. 2013 Sep; 99(3):405-8. PMID: 23832086.
    Citations:    
  116. Naranbhai V, Samsunder N, Sandler NG, Roque A, Abdool Karim Q, Ndung'u T, Carr WH, Altfeld M, Douek DC, Abdool Karim SS. Neither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004. J Acquir Immune Defic Syndr. 2013 Jul 01; 63(3):294-8. PMID: 23481666.
    Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
  117. Moore PL, Sheward D, Nonyane M, Ranchobe N, Hermanus T, Gray ES, Abdool Karim SS, Williamson C, Morris L. Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies. J Virol. 2013 May; 87(9):4882-94. PMID: 23408621.
    Citations:    
  118. Naidoo K, Baxter C, Abdool Karim SS. When to start antiretroviral therapy during tuberculosis treatment? Curr Opin Infect Dis. 2013 Feb; 26(1):35-42. PMID: 23188213.
    Citations:    
  119. Mayosi BM, Lawn JE, van Niekerk A, Bradshaw D, Abdool Karim SS, Coovadia HM. Health in South Africa: changes and challenges since 2009. Lancet. 2012 Dec 08; 380(9858):2029-43. PMID: 23201214.
    Citations:    
  120. Grobler A, Abdool Karim S. Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial. AIDS. 2012 Nov 13; 26(17):2261; author reply 2262-3. PMID: 23123519.
    Citations:    
  121. Moore PL, Gray ES, Wibmer CK, Bhiman JN, Nonyane M, Sheward DJ, Hermanus T, Bajimaya S, Tumba NL, Abrahams MR, Lambson BE, Ranchobe N, Ping L, Ngandu N, Abdool Karim Q, Abdool Karim SS, Swanstrom RI, Seaman MS, Williamson C, Morris L. Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. Nat Med. 2012 Nov; 18(11):1688-92. PMID: 23086475.
    Citations: 117     Fields:    Translation:HumansCells
  122. Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mlotshwa M, Madlala BT, Abdool Karim SS. HIV incidence in young girls in KwaZulu-Natal, South Africa--public health imperative for their inclusion in HIV biomedical intervention trials. AIDS Behav. 2012 Oct; 16(7):1870-6. PMID: 22618892.
    Citations:    
  123. Naranbhai V, Altfeld M, Abdool Karim Q, Ndung'u T, Abdool Karim SS, Carr WH. Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial. AIDS. 2012 Sep 10; 26(14):1745-53. PMID: 22781225.
    Citations: 10     Fields:    Translation:HumansCells
  124. Riou C, Treurnicht F, Abrahams MR, Mlisana K, Liu MK, Goonetilleke N, Koup R, Roederer M, Abdool Karim S, de Bruyn G, Williamson C, Gray CM, Burgers WA. Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for cytomegalovirus-specific CD8+ T cells. J Immunol. 2012 Oct 15; 189(8):3838-47. PMID: 22966086.
    Citations:    
  125. Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC. Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis. 2012 Dec 15; 206(12):1931-5. PMID: 22966121.
    Citations:    
  126. Naidoo K, Yende-Zuma N, Padayatchi N, Naidoo K, Jithoo N, Nair G, Bamber S, Gengiah S, El-Sadr WM, Friedland G, Abdool Karim S. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. Ann Intern Med. 2012 Sep 04; 157(5):313-24. PMID: 22944873.
    Citations:    
  127. Ntale RS, Chopera DR, Ngandu NK, Assis de Rosa D, Zembe L, Gamieldien H, Mlotshwa M, Werner L, Woodman Z, Mlisana K, Abdool Karim S, Gray CM, Williamson C. Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression. J Virol. 2012 Nov; 86(22):12013-24. PMID: 22933291.
    Citations:    
  128. Wecker M, Gilbert P, Russell N, Hural J, Allen M, Pensiero M, Chulay J, Chiu YL, Abdool Karim SS, Burke DS. Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults. Clin Vaccine Immunol. 2012 Oct; 19(10):1651-60. PMID: 22914365.
    Citations:    
  129. Naranbhai V, Abdool Karim SS, Altfeld M, Samsunder N, Durgiah R, Sibeko S, Abdool Karim Q, Carr WH. Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. J Infect Dis. 2012 Oct 01; 206(7):993-1001. PMID: 22829639.
    Citations: 56     Fields:    Translation:HumansCells
  130. Abdool Karim SS. An AIDS-free generation? Science. 2012 Jul 13; 337(6091):133. PMID: 22798569.
    Citations:    
  131. Abdool Karim SS, Gray GE, Martinson N. Clinical decisions. Preexposure prophylaxis for HIV prevention. N Engl J Med. 2012 Aug 02; 367(5):462-5. PMID: 22784042.
    Citations:    
  132. Mureithi MW, Poole D, Naranbhai V, Reddy S, Mkhwanazi NP, Sibeko S, Werner L, Abdool Karim Q, Abdool Karim S, Ndung'u T, Altfeld M. Preservation HIV-1-specific IFN?+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial. J Acquir Immune Defic Syndr. 2012 Jun 01; 60(2):124-7. PMID: 22362152.
    Citations: 7     Fields:    Translation:HumansCells
  133. Taylor DJ, Grobler A, Abdool Karim SS. An adaptive design to bridge the gap between Phase 2b/3 microbicide effectiveness trials and evidence required for licensure. Clin Trials. 2012 Aug; 9(4):377-84. PMID: 22610168.
    Citations:    
  134. Lynch RM, Tran L, Louder MK, Schmidt SD, Cohen M, Dersimonian R, Euler Z, Gray ES, Abdool Karim S, Kirchherr J, Montefiori DC, Sibeko S, Soderberg K, Tomaras G, Yang ZY, Nabel GJ, Schuitemaker H, Morris L, Haynes BF, Mascola JR. The development of CD4 binding site antibodies during HIV-1 infection. J Virol. 2012 Jul; 86(14):7588-95. PMID: 22573869.
    Citations: 53     Fields:    Translation:HumansCells
  135. Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, Passmore JA, Grobler AC, Sturm AW, Williamson C, Ronacher K, Walzl G, Abdool Karim SS. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012 Jul 01; 206(1):6-14. PMID: 22517910.
    Citations:    
  136. Kharsany AB, Mlotshwa M, Frohlich JA, Yende Zuma N, Samsunder N, Abdool Karim SS, Abdool Karim Q. HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services. BMC Public Health. 2012 Mar 22; 12:231. PMID: 22439635.
    Citations:    
  137. Grobler AC, Abdool Karim SS. Design challenges facing clinical trials of the effectiveness of new HIV-prevention technologies. AIDS. 2012 Mar 13; 26(5):529-32. PMID: 22210638.
    Citations:    
  138. Gengiah TN, Baxter C, Mansoor LE, Kharsany AB, Abdool Karim SS. A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection. Expert Opin Investig Drugs. 2012 May; 21(5):695-715. PMID: 22394224.
    Citations:    
  139. Abdool Karim SS, Baxter C. Overview of microbicides for the prevention of human immunodeficiency virus. Best Pract Res Clin Obstet Gynaecol. 2012 Aug; 26(4):427-39. PMID: 22386823.
    Citations:    
  140. Roberts L, Passmore JA, Mlisana K, Williamson C, Little F, Bebell LM, Walzl G, Abrahams MR, Woodman Z, Abdool Karim Q, Abdool Karim SS. Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women. J Infect Dis. 2012 Jan 15; 205(2):194-203. PMID: 22190580.
    Citations: 25     Fields:    Translation:HumansCells
  141. Abdool Karim SS. Antiretroviral pre-exposure prophylaxis; new hope and conundrums. J Watch AIDS Clin Care. 2012 Jan; 24(1):1-2. PMID: 26223036.
    Citations:    
  142. Boily MC, Dimitrov D, Abdool Karim SS, Mâsse B. The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention. Sex Transm Infect. 2011 Dec; 87(7):646-53. PMID: 22110117.
    Citations:    
  143. Gengiah TN, Holford NH, Botha JH, Gray AL, Naidoo K, Abdool Karim SS. The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis. Eur J Clin Pharmacol. 2012 May; 68(5):689-95. PMID: 22108776.
    Citations:    
  144. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, Gengiah T, Gengiah S, Naidoo A, Jithoo N, Nair G, El-Sadr WM, Friedland G, Abdool Karim Q. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011 Oct 20; 365(16):1492-501. PMID: 22010915.
    Citations:    
  145. Williams BG, Abdool Karim SS, Karim QA, Gouws E. Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa. J Acquir Immune Defic Syndr. 2011 Oct 01; 58(2):207-10. PMID: 21654503.
    Citations:    
  146. Morris L, Chen X, Alam M, Tomaras G, Zhang R, Marshall DJ, Chen B, Parks R, Foulger A, Jaeger F, Donathan M, Bilska M, Gray ES, Abdool Karim SS, Kepler TB, Whitesides J, Montefiori D, Moody MA, Liao HX, Haynes BF. Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting. PLoS One. 2011; 6(9):e23532. PMID: 21980336.
    Citations: 75     Fields:    Translation:HumansCells
  147. Madlala P, Gijsbers R, Christ F, Hombrouck A, Werner L, Mlisana K, An P, Abdool Karim SS, Winkler CA, Debyser Z, Ndung'u T. Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression. AIDS. 2011 Sep 10; 25(14):1711-9. PMID: 21681054.
    Citations: 14     Fields:    Translation:HumansCells
  148. Tomaras GD, Binley JM, Gray ES, Crooks ET, Osawa K, Moore PL, Tumba N, Tong T, Shen X, Yates NL, Decker J, Wibmer CK, Gao F, Alam SM, Easterbrook P, Abdool Karim S, Kamanga G, Crump JA, Cohen M, Shaw GM, Mascola JR, Haynes BF, Montefiori DC, Morris L. Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals. J Virol. 2011 Nov; 85(21):11502-19. PMID: 21849452.
    Citations:    
  149. Abdool Karim SS. Stigma impedes AIDS prevention. Nature. 2011 Jun 02; 474(7349):29-31. PMID: 21637237.
    Citations:    
  150. Chopera DR, Mlotshwa M, Woodman Z, Mlisana K, de Assis Rosa D, Martin DP, Abdool Karim S, Gray CM, Williamson C. Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individuals. J Virol. 2011 Jul; 85(14):7070-80. PMID: 21613398.
    Citations:    
  151. Gray ES, Moody MA, Wibmer CK, Chen X, Marshall D, Amos J, Moore PL, Foulger A, Yu JS, Lambson B, Abdool Karim S, Whitesides J, Tomaras GD, Haynes BF, Morris L, Liao HX. Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual. J Virol. 2011 Aug; 85(15):7719-29. PMID: 21613396.
    Citations:    
  152. Abdool Karim SS. Update on pre-exposure prophylaxis. J Watch AIDS Clin Care. 2011 May; 23(5):37-8. PMID: 27652425.
    Citations:    
  153. Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011 Apr 24; 25(7):957-66. PMID: 21330907.
    Citations:    
  154. Gray ES, Madiga MC, Hermanus T, Moore PL, Wibmer CK, Tumba NL, Werner L, Mlisana K, Sibeko S, Williamson C, Abdool Karim SS, Morris L. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection. J Virol. 2011 May; 85(10):4828-40. PMID: 21389135.
    Citations:    
  155. Moore PL, Gray ES, Sheward D, Madiga M, Ranchobe N, Lai Z, Honnen WJ, Nonyane M, Tumba N, Hermanus T, Sibeko S, Mlisana K, Abdool Karim SS, Williamson C, Pinter A, Morris L. Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop. J Virol. 2011 Apr; 85(7):3128-41. PMID: 21270156.
    Citations:    
  156. Abdool Karim SS, Baxter C. Microbicides & their implications in HIV prevention. Indian J Med Res. 2010 Dec; 132:656-9. PMID: 21245610.
    Citations:    
  157. Abdool Karim Q, Abdool Karim SS, Baxter C, Friedland G, Gengiah T, Gray A, Grobler A, Naidoo K, Padayatchi N, El-Sadr W. The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis. S Afr Med J. 2010 Dec 01; 100(12):808-9. PMID: 21414268.
    Citations:    
  158. Karim QA, Kharsany AB, Frohlich JA, Werner L, Mashego M, Mlotshwa M, Madlala BT, Ntombela F, Abdool Karim SS. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol. 2011 Aug; 40(4):922-30. PMID: 21047913.
    Citations:    
  159. Kharsany AB, Hancock N, Frohlich JA, Humphries HR, Abdool Karim SS, Abdool Karim Q. Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa. HIV Med. 2010 Nov; 11(10):661-5. PMID: 20497252.
    Citations:    
  160. Mlotshwa M, Riou C, Chopera D, de Assis Rosa D, Ntale R, Treunicht F, Woodman Z, Werner L, van Loggerenberg F, Mlisana K, Abdool Karim S, Williamson C, Gray CM. Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression. J Virol. 2010 Nov; 84(22):12018-29. PMID: 20826686.
    Citations:    
  161. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010 Sep 03; 329(5996):1168-74. PMID: 20643915.
    Citations:    
  162. Naidoo K, Abdool Karim SS. TMP-SMX prophylaxis reduces mortality among African patients on ART. J Watch AIDS Clin Care. 2010 Jun; 22(6):49-50. PMID: 20648964.
    Citations:    
  163. Abdool Karim SS. ART and pregnancy rates. J Watch AIDS Clin Care. 2010 Jun; 22(6):52. PMID: 20665944.
    Citations:    
  164. Abdool Karim SS. Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials. Future Microbiol. 2010 Apr; 5(4):527-9. PMID: 20353292.
    Citations:    
  165. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, Khan M, Pienaar J, El-Sadr W, Friedland G, Abdool Karim Q. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010 Feb 25; 362(8):697-706. PMID: 20181971.
    Citations:    
  166. Reddy K, Winkler CA, Werner L, Mlisana K, Abdool Karim SS, Ndung'u T. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load. AIDS. 2010 Jan 16; 24(2):195-204. PMID: 19996938.
    Citations:    
  167. Abdool Karim SS. HIV vaccine and microbicide trials turn a corner. We still don't have an effective vaccine or microbicide for the clinic, but two major trials this year brought us closer than we've ever been. J Watch AIDS Clin Care. 2010 Jan; 22(1):2. PMID: 20617574.
    Citations:    
  168. Moore PL, Ranchobe N, Lambson BE, Gray ES, Cave E, Abrahams MR, Bandawe G, Mlisana K, Abdool Karim SS, Williamson C, Morris L. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog. 2009 Sep; 5(9):e1000598. PMID: 19763271.
    Citations:    
  169. Abdool Karim SS, Churchyard GJ, Karim QA, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009 Sep 12; 374(9693):921-33. PMID: 19709731.
    Citations:    
  170. Gray ES, Madiga MC, Moore PL, Mlisana K, Abdool Karim SS, Binley JM, Shaw GM, Mascola JR, Morris L. Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region. J Virol. 2009 Nov; 83(21):11265-74. PMID: 19692477.
    Citations:    
  171. Abdool Karim SS. Commentary: Spatial clustering of HIV infection: providing clues for effective HIV prevention. Int J Epidemiol. 2009 Aug; 38(4):1016-7. PMID: 19406907.
    Citations:    
  172. Abdool Karim SS. Top stories of 2008. The prospect of PrEP. AIDS Clin Care. 2009 Jan; 21(1):6. PMID: 19226670.
    Citations:    
  173. van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, Abdool Karim Q, Grobler A, Barnabas N, Iriogbe I, Abdool Karim SS. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One. 2008 Apr 16; 3(4):e1954. PMID: 18414658.
    Citations: 90     Fields:    Translation:Humans
  174. Mlisana K, Auld SC, Grobler A, van Loggerenberg F, Williamson C, Iriogbe I, Sobieszczyk ME, Abdool Karim SS. Anaemia in acute HIV-1 subtype C infection. PLoS One. 2008 Feb 20; 3(2):e1626. PMID: 18286183.
    Citations: 7     Fields:    Translation:HumansCells
  175. Moore PL, Gray ES, Choge IA, Ranchobe N, Mlisana K, Abdool Karim SS, Williamson C, Morris L. The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J Virol. 2008 Feb; 82(4):1860-9. PMID: 18057243.
    Citations:    
  176. Abdool Karim SS, Abdool Karim Q. Diverse approaches useful for microbicide trials. Nature. 2007 Sep 06; 449(7158):24. PMID: 17805274.
    Citations:    
  177. Frohlich JA, Abdool Karim Q, Mashego MM, Sturm AW, Abdool Karim SS. Opportunities for treating sexually transmitted infections and reducing HIV risk in rural South Africa. J Adv Nurs. 2007 Nov; 60(4):377-83. PMID: 17822425.
    Citations:    
  178. Abdool Karim SS, Abdool Karim Q, Gouws E, Baxter C. Global epidemiology of HIV-AIDS. Infect Dis Clin North Am. 2007 Mar; 21(1):1-17, vii. PMID: 17502227.
    Citations:    
  179. Dilraj A, Abdool Karim SS, Pillay S. Challenging racial stereotyping of AIDS in South Africa with prevalence of HIV in pregnant women. S Afr Med J. 2007 Jan; 97(1):42, 44. PMID: 17378281.
    Citations:    
  180. Abdool Karim SS. Report from the XVI International AIDS Conference. SMART and DART: intermittent antiretroviral treatment is suboptimal and should be avoided. AIDS Clin Care. 2006 Nov; 18(11):100. PMID: 17183746.
    Citations:    
  181. Amirfar S, Hollenberg JP, Abdool Karim SS. Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa. J Acquir Immune Defic Syndr. 2006 Oct 01; 43(2):219-25. PMID: 16951648.
    Citations:    
  182. Gray A, Abdool Karim SS, Gengiah TN. Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis-HIV-co-infected patients in resource-constrained settings. AIDS. 2006 Jan 09; 20(2):302-3. PMID: 16511431.
    Citations:    
  183. Kharsany AB, Connolly C, Olowolagba A, Abdool Karim SS, Abdool Karim Q. TB treatment outcomes following directly-observed treatment at an urban outpatient specialist TB facility in South Africa. Trop Doct. 2006 Jan; 36(1):23-5. PMID: 16483424.
    Citations:    
  184. Abdool Karim SS. Top stories of 2004. DNA-MVA prime boost: another vaccine candidate bites the dust. AIDS Clin Care. 2005 Jan; 17(1):5. PMID: 15717370.
    Citations:    
  185. Myer L, Abdool Karim SS, Lombard C, Wilkinson D. Treatment of maternal syphilis in rural South Africa: effect of multiple doses of benzathine penicillin on pregnancy loss. Trop Med Int Health. 2004 Nov; 9(11):1216-21. PMID: 15548319.
    Citations:    
  186. Abdool Karim SS. Meeting report from the XV International AIDS Conference. Prevention. AIDS Clin Care. 2004 Sep; 16(9):75, 78. PMID: 15540321.
    Citations:    
  187. Friedland G, Abdool Karim S, Abdool Karim Q, Lalloo U, Jack C, Gandhi N, El Sadr W. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. Clin Infect Dis. 2004 Jun 01; 38 Suppl 5:S421-8. PMID: 15156433.
    Citations:    
  188. Abdool Karim SS. Medical education after the first decade of democracy in South Africa. Lancet. 2004 Apr 24; 363(9418):1395. PMID: 15112696.
    Citations:    
  189. Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, Eshleman SH, Fleming T, Emel L, George K, Katzenstein DA, Wells J, Maponga CC, Mwatha A, Jones SA, Abdool Karim SS, Bassett MT. Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):482-90. PMID: 14657758.
    Citations:    
  190. Abdool Karim SS, Abdool Karim Q, Baxter C. Antiretroviral therapy: challenges and options in South Africa. Lancet. 2003 Nov 01; 362(9394):1499. PMID: 14602450.
    Citations:    
  191. Morrow K, Rosen R, Richter L, Emans A, Forbes A, Day J, Morar N, Maslankowski L, Profy AT, Kelly C, Abdool Karim SS, Mayer KH. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. J Womens Health (Larchmt). 2003 Sep; 12(7):655-66. PMID: 14583106.
    Citations: 44     Fields:    Translation:HumansCTClinical Trials
  192. Lurie MN, Williams BG, Zuma K, Mkaya-Mwamburi D, Garnett G, Sturm AW, Sweat MD, Gittelsohn J, Abdool Karim SS. The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis. 2003 Feb; 30(2):149-56. PMID: 12567174.
    Citations:    
  193. Connolly CA, Ramjee G, Sturm AW, Abdool Karim SS. Incidence of Sexually Transmitted Infections among HIV-positive sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis. 2002 Nov; 29(11):721-4. PMID: 12438911.
    Citations:    
  194. Abdool Karim SS, Currier J, del Rio C, Feinberg J, Friedland GH, Sax PE, Zuger A. Report on the XIV International AIDS Conference. AIDS Clin Care. 2002 Sep; 14(9):77-85. PMID: 12236208.
    Citations:    Fields:    Translation:Humans
  195. Abdool Karim S, Abdool Karim Q, Adhikari M, Cassol S, Chersich M, Cooper P, Coovadia A, Coovadia H, Cotton M, Coutsoudis A, Hide W, Hussey G, Maartens G, Madhi S, Martin D, Pettifor JM, Rollins N, Sherman G, Thula S, Urban M, Velaphi S, Williamson C. Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet. 2002 Mar 23; 359(9311):992-3. PMID: 11937176.
    Citations: 1     Fields:    Translation:Humans
  196. Abdool Karim SS, Abdool Karim Q. Breaking the silence, one year later: reflections on the Durban Conference. AIDS Clin Care. 2001 Jul; 13(7):63-5, 70. PMID: 11683137.
    Citations:    
  197. Abdool Karim SS. Globalization, ethics, and AIDS vaccines. Science. 2000 Jun 23; 288(5474):2129. PMID: 10896579.
    Citations:    
  198. Wilkinson D, Abdool Karim SS, Williams B, Gouws E. High HIV incidence and prevalence among young women in rural South Africa: developing a cohort for intervention trials. J Acquir Immune Defic Syndr. 2000 Apr 15; 23(5):405-9. PMID: 10866233.
    Citations:    
  199. Rustomjee R, Abdool Karim Q, Abdool Karim SS, Laga M, Stein Z. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. AIDS. 1999 Aug 20; 13(12):1511-5. PMID: 10465075.
    Citations:    
  200. Abdool Karim Q, Abdool Karim SS. South Africa: host to a new and emerging HIV epidemic. Sex Transm Infect. 1999 Jun; 75(3):139-40. PMID: 10448384.
    Citations:    
  201. Abdool Karim SS. Making AIDS a notifiable disease--is it an appropriate policy for South Africa? S Afr Med J. 1999 Jun; 89(6):609-11. PMID: 10443205.
    Citations:    
  202. Wilkinson D, Harrison A, Lurie M, Abdool Karim SS. STD syndrome packets: improving syndromic management of sexually transmitted diseases in developing countries. Sex Transm Dis. 1999 Mar; 26(3):152-6. PMID: 10100772.
    Citations:    
  203. Wilkinson D, Abdool Karim SS, Harrison A, Lurie M, Colvin M, Connolly C, Sturm AW. Unrecognized sexually transmitted infections in rural South African women: a hidden epidemic. Bull World Health Organ. 1999; 77(1):22-8. PMID: 10063657.
    Citations:    
  204. Colvin M, Abdool Karim SS, Connolly C, Hoosen AA, Ntuli N. HIV infection and asymptomatic sexually transmitted infections in a rural South African community. Int J STD AIDS. 1998 Sep; 9(9):548-50. PMID: 9764941.
    Citations:    
  205. Morar NS, Ramjee G, Abdool Karim SS. Vaginal insertion and douching practices among sex workers at truck stops in KwaZulu-Natal. S Afr Med J. 1998 Apr; 88(4):470. PMID: 9594997.
    Citations:    
  206. Abdool Karim Q, Abdool Karim SS, Coovadia HM, Susser M. Informed consent for HIV testing in a South African hospital: is it truly informed and truly voluntary? Am J Public Health. 1998 Apr; 88(4):637-40. PMID: 9551007.
    Citations:    
  207. Abdool Karim SS. Placebo controls in HIV perinatal transmission trials: a South African's viewpoint. Am J Public Health. 1998 Apr; 88(4):564-6. PMID: 9550994.
    Citations:    
  208. Abdool Karim SS. Measuring effectiveness of tuberculosis control programmes. S Afr Med J. 1997 Aug; 87(8 Suppl):1040-1. PMID: 9323426.
    Citations:    
  209. Lurie M, Wilkinson D, Harrison A, Abdool Karim S. Migrancy and HIV/STDs in South Africa--a rural perspective. S Afr Med J. 1997 Jul; 87(7):908-9. PMID: 9259737.
    Citations:    
  210. Anastasis D, Pillai G, Rambiritch V, Abdool Karim SS. A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis. 1997 Jun; 1(3):220-4. PMID: 9432367.
    Citations:    
  211. Benatar SR, Folb PI, van Niekerk JP, Bothwell TH, Ncayiyana DJ, Jacobs M, McCoy D, Abdool Karim SS, Makgoba MW, Prozesky OW, Kirsch R. Country profile. South Africa. Lancet. 1997 May 24; 349(9064):1537-45. PMID: 9167473.
    Citations:    
  212. Wilkinson D, Cutts F, Ntuli N, Abdool Karim SS. Maternal and child health indicators in a rural South African health district. S Afr Med J. 1997 Apr; 87(4):456-9. PMID: 9254790.
    Citations:    
  213. Kay BJ, Katzenellenbogen J, Fawcus S, Abdool Karim S. An analysis of the cost of incomplete abortion to the public health sector in South Africa--1994. S Afr Med J. 1997 Apr; 87(4):442-7. PMID: 9254787.
    Citations:    
  214. Wilkinson D, Sach ME, Abdool Karim SS. Examination of attendance patterns before and after introduction of South Africa's policy of free health care for children aged under 6 years and pregnant women. BMJ. 1997 Mar 29; 314(7085):940-1. PMID: 9099118.
    Citations:    
  215. Anastasis D, Pillai G, Rambiritch V, Abdool Karim SS. Multidrug-resistant tuberculosis in patients without HIV infection. S Afr Med J. 1996 Oct; 86(10):1294-6. PMID: 8955742.
    Citations:    
  216. Abdool Karim SS, Chapman A, Shapiro JB. Rationalisation of data collection for a child health service. S Afr Med J. 1996 Jul; 86(7):837. PMID: 8764912.
    Citations:    
  217. Abdool Karim SS, Dilraj A. Reasons for under-reporting of notifiable conditions. S Afr Med J. 1996 Jul; 86(7):834-6. PMID: 8764911.
    Citations:    
  218. Colvin M, Abdool Karim SS, Wilkinson D. Migration and AIDS. Lancet. 1995 Nov 11; 346(8985):1303-4. PMID: 7475752.
    Citations:    
  219. Abdool Karim SS. Challenges to the control of sexually transmitted diseases in Africa. Am J Public Health. 1994 Dec; 84(12):1891-3. PMID: 7998624.
    Citations:    
  220. Robson SC, Schoub B, Abdool Karim SS. Viral hepatitis B--an overview. S Afr Med J. 1994 Aug; 84(8 Pt 2):530-5. PMID: 7863395.
    Citations:    
  221. Kirsch RE, Abdool Karim SS, Prozesky OW. Why viral hepatitis? S Afr Med J. 1994 Aug; 84(8 Pt 2):523-4. PMID: 7863392.
    Citations:    
  222. Buchel E, Hift RJ, Wilson T, Abdool Karim SS. The prevention of hepatitis. S Afr Med J. 1994 Aug; 84(8 Pt 2):578-83. PMID: 7863405.
    Citations:    
  223. Colvin MS, Abdool Karim SS, Gouws E. Occupational disease in a chromate producing factory. S Afr Med J. 1993 Nov; 83(11):857-8. PMID: 7839222.
    Citations:    
  224. Abdool Karim SS, Coutsoudis A. Sero-epidemiology of hepatitis A in black South African children. S Afr Med J. 1993 Oct; 83(10):748-50. PMID: 8191332.
    Citations:    
  225. Soni PN, Abdool Karim SS, Coovadia HM, Hurribunce AC, Jinabhai CC, Mokoena T, Moodley J, Seedat MA. Academic health complexes--ivory towers or national resources? S Afr Med J. 1993 Jul; 83(7):464-5. PMID: 8211480.
    Citations:    
  226. Abdool Karim SS. Traditional healers and AIDS prevention. S Afr Med J. 1993 Jun; 83(6):423-5. PMID: 8211461.
    Citations:    
  227. Abdool Karim SS, Abdool Karim Q, Dilraj A, Chamane M. Unsustainability of a measles immunisation campaign--rise in measles incidence within 2 years of the campaign. S Afr Med J. 1993 May; 83(5):322-3. PMID: 8211424.
    Citations:    
  228. Abdool Karim SS, Tait DR. Hepatitis C virus infection in urban and rural Natal/KwaZulu. S Afr Med J. 1993 Mar; 83(3):191-3. PMID: 8390100.
    Citations:    
  229. Abdool Karim SS, Abdool Karim Q. Changes in HIV seroprevalence in a rural black community in KwaZulu. S Afr Med J. 1992 Dec; 82(6):484. PMID: 1465707.
    Citations:    
  230. Abdool Karim Q, Abdool Karim SS, Singh B, Short R, Ngxongo S. Seroprevalence of HIV infection in rural South Africa. AIDS. 1992 Dec; 6(12):1535-9. PMID: 1492937.
    Citations:    
  231. Abdool Karim Q, Abdool Karim SS, Preston-Whyte E. Teenagers seeking condoms at family planning services. Part II. A provider's perspective. S Afr Med J. 1992 Nov; 82(5):360-2. PMID: 1448721.
    Citations:    
  232. Abdool Karim Q, Preston-Whyte E, Abdool Karim SS. Teenagers seeking condoms at family planning services. Part I. A user's perspective. S Afr Med J. 1992 Nov; 82(5):356-9. PMID: 1448720.
    Citations:    
  233. Abdool Karim SS, Abdool Karim Q, Preston-Whyte E, Sankar N. Reasons for lack of condom use among high school students. S Afr Med J. 1992 Aug; 82(2):107-10. PMID: 1509321.
    Citations:    
  234. Abdool Karim SS, Abdool Karim Q, Chamane M. Impact of a measles immunisation campaign on measles admissions to a Natal hospital. S Afr Med J. 1991 Dec 07; 80(11-12):579-81. PMID: 1745947.
    Citations:    
  235. Abdool Karim Q, Abdool Karim SS, Nkomokazi J. Sexual behaviour and knowledge of AIDS among urban black mothers. Implications for AIDS intervention programmes. S Afr Med J. 1991 Oct 05; 80(7):340-3. PMID: 1925842.
    Citations:    
  236. Abdool Karim SS, Windsor IM, Gopaul W. Low prevalence of delta hepatitis virus infection among blacks in Natal. S Afr Med J. 1991 Aug 17; 80(4):193-4. PMID: 1876956.
    Citations:    
  237. Abdool Karim SS, Andelman R. Impact of the political violence in Natal on emergency surgical services of a tertiary hospital. S Afr Med J. 1991 Aug 03; 80(3):134-8. PMID: 1862446.
    Citations:    
  238. Abdool Karim SS, Thejpal R, Coovadia HM. Household clustering and intra-household transmission patterns of hepatitis B virus infection in South Africa. Int J Epidemiol. 1991 Jun; 20(2):495-503. PMID: 1917255.
    Citations:    
  239. Abdool Karim SS, Abdool Karim Q. Under-reporting in hepatitis B notifications. S Afr Med J. 1991 Mar 02; 79(5):242-4. PMID: 2011799.
    Citations:    
  240. Abdool Karim SS. Should AIDS be made notifiable? S Afr Med J. 1991 Feb 16; 79(4):179-81. PMID: 1996432.
    Citations:    
  241. Kiepiela P, Coovadia HM, Loening WE, Coward P, Abdool Karim SS. Loss of maternal measles antibody in black South African infants in the first year of life--implications for age of vaccination. S Afr Med J. 1991 Feb 02; 79(3):145-8. PMID: 1994484.
    Citations:    
  242. Rutkove SB, Abdool Karim SS, Loening WE. Patterns of care in an overburdened tertiary hospital outpatients department. S Afr Med J. 1990 May 05; 77(9):476-8. PMID: 2339314.
    Citations:    Fields:    Translation:Humans
  243. Abdool Karim SS, Thejpal R, Singh B. High prevalence of hepatitis B virus infection in rural black adults in Mseleni, South Africa. Am J Public Health. 1989 Jul; 79(7):893-4. PMID: 2735483.
    Citations:    
  244. Abdool Karim SS, Coovadia HM, Windsor IM, Thejpal R, van den Ende J, Fouche A. The prevalence and transmission of hepatitis B virus infection in urban, rural and institutionalized black children of Natal/KwaZulu, South Africa. Int J Epidemiol. 1988 Mar; 17(1):168-73. PMID: 2898434.
    Citations:    
  245. Fouché A, Abdool Karim SS, Windsor IM, van den Ende JE. Hepatitis B virus in a culicine mosquito species in the RSA. S Afr Med J. 1986 Aug 30; 70(5):302. PMID: 3750129.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Abdool Karim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (653)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.